Browse All
Displaying 6 - 8 of 8
Author:Bove, Riley Pia Amato, Maria Dobson, Ruth M. Krysko, Kristen Stoll, Sharon Vukusic, Sandra Yamout, Bassem Zielman, Ronald Krishna Gummuluri, Swetha Jehl, Valentine Schulze Topphoff, Ulf Sullivan, Roseanne Fantaccini, Simone Hellwig, Kerstin
Session Name:P9: MS Special Populations
Topic:MS and Inflammatory Disease
Program Number:P9.014
Author Institution:UCSF Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA, Berkeley, CA Department NEUROFARBA, University of Florence, Florence, Italy IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy, Florence, Italy Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom, London, United Kingdom Division of Neurology, Department of Medicine, St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, Ontario, Canada, Toronto, ON, Canada Department of Neurology, Yale University, New Haven, Connecticut, USA, New Haven, CT Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Hôpital neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France Centre des Neurosciences de Lyon, INSERM 1028 et CNRS UMR5292, Observatoire Français de la Sclérose en Plaques, Lyon, France Université Claude Bernard Lyon 1, Villeurbanne, France, BRON Cedex, France American University of Beirut Medical Center, Beirut, Lebanon Harley Street Medical Centre, Abu Dhabi, UAE, Beirut, Lebanon Novartis Pharma B.V., Amsterdam, The Netherlands, Haaksbergweg, Netherlands Novartis Healthcare Pvt Ltd, Hyderabad, India, Hyderabad, India Novartis Pharma A.G. Basel, Switzerland, Basel, Switzerland Novartis Pharma GmbH, Germany, Nuernberg, Germany Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA, East Hanover, NJ Novartis Pharma A.G. Basel, Switzerland, Binningen, Switzerland St. Josef-Hospital/Ruhr-University Bochum, Bochum, Germany, Bochum, Germany
Author:Shah, Anna Bove, Riley Applebee, Angela Bawden, Katrina Fine, Celeste Avila, Robin Belviso, Nicholas Branco, Filipe Fong, Kinyee Lewin, James Liu, Jieruo England, Sarah Vignos, Megan
Program Number:P9.016
Author Institution:University of Colorado, Rocky Mountain MS Center, Aurora, CO Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA St. Peter's Health Partners, Albany, NY Rocky Mountain MS Clinic, Salt Lake City, UT Gilbert Neurology, Mesa, AZ Biogen Inc., Cambridge, MA
Author:Novak, Frederik Bajwa, Hamza Eugenio Coia, John Nilsson, Anna Christine Nielsen, Christian Holm, Dorte Østergaard, Kamilla Hvidt, Mathilde Byg, Keld-Erik Johansen, Isik Mittl, Kristen Rowles, William Zamvil, Scott Bove, Riley Sabatino, Joseph Sejbaek, Tobias
Session Name:P12: MS COVID and Clinical Practice
Program Number:P12.005
Author Institution:Southwest Jutland Hospital, Esbjerg, Denmark University of Southern Denmark, Odense, Denmark Odense University Hospital, Odense, Denmark Nordsjællands Hospital, Hillerød, Denmark Hospitalsenhed Midt, Viborg, Denmark UCSF, San Francisco, CA University of CA, San Francisco, San Francisco, CA University of California, San Francisco, Berkeley, CA University of California San Francisco, San Francisco, CA
